Neon Bloom, Inc. (NBCO) Stock Analysis
For informational purposes only. Not financial advice. Analysis by Sedat ANAK, Founder & Editor-in-Chief | AI-powered analysis. Data sourced from SEC filings and institutional-grade financial providers. Editorially reviewed. Not financial advice.
Neon Bloom, Inc. (NBCO) trades at $0.0053. Neon Bloom, Inc. is a principal investment firm focused on acquiring innovative agriculture and ancillary technology companies. Market cap: $1.12M, Sector: Healthcare.
Price as of Aug 21, 2026 · Last analyzed: Mar 17, 2026Analyst Coverage for NBCO: NBCO does not currently have published analyst price targets in our coverage universe. This is common for smaller-cap names with limited Wall Street coverage. In the absence of analyst consensus, our AI model evaluates NBCO against Healthcare peers across nine fundamental dimensions and assigns an underweight signal based on the underlying data.
NBCO: 2/3 scored disciplines lean bearish. Dominant signal: Izzy Englander bullish.
How is this calculated? →Neon Bloom, Inc. (NBCO) Healthcare & Pipeline Overview
Neon Bloom, Inc., founded in 2015, is a principal investment firm specializing in the acquisition of innovative agriculture and ancillary technology companies within the biotechnology sector, demonstrating a focus on strategic investments despite its small size and negative profit margins.
What Is the Investment Thesis for NBCO?
Neon Bloom, Inc. presents a unique investment profile as a principal investment firm specializing in agriculture and ancillary technology acquisitions. With a market capitalization of $1.12M and a negative P/E ratio of -0.96, the company's current valuation metrics suggest it is not yet profitable. However, its focus on innovative sectors could drive future growth. The investment thesis hinges on Neon Bloom's ability to successfully identify, acquire, and integrate promising companies within its target sectors. Key catalysts include successful acquisitions and subsequent revenue growth within acquired entities. The primary risk involves the firm's ability to manage its investments effectively and achieve profitability, given its current financial metrics and small operational size.
Based on FMP financials and quantitative analysis
NBCO Key Highlights
Market Cap: $0.00B indicates a micro-cap company with limited market presence.
- P/E Ratio: -0.96 suggests the company is currently not profitable.
- Profit Margin: -8.1% reflects ongoing losses, indicating a need for improved operational efficiency or revenue growth.
- Gross Margin: 12.6% shows a small percentage of revenue remaining after deducting the cost of goods sold.
- Beta: 0.41 suggests the stock is less volatile than the overall market.
Who Are NBCO's Competitors?
NBCO is benchmarked below against 8 industry peers on price, market cap, and our AI MoonshotScore.
| Company | Price | Change | Market Cap | AI Score |
|---|---|---|---|---|
| CAIHF Chia Tai Enterprises International Limited | $1.07 | +0.00% | $258M | 53 |
| GRTX Galera Therapeutics, Inc. | $17.15 | +9.80% | $3.56B | 50 |
| ADAPY Adaptimmune Therapeutics plc | $0.03 | +0.00% | $7.16M | 72 |
| RLYB Rallybio Corporation | $16.60 | -2.35% | $88.1M | 81 |
| ICCC ImmuCell Corporation | $10.09 | -0.39% | $91.3M | 77 |
| JNCE Jounce Therapeutics, Inc. | $1.88 | +0.00% | $99.0M | 71 |
| ORMP Oramed Pharmaceuticals Inc. | $4.79 | +0.00% | $196M | 77 |
| CGEN Compugen Ltd. | $2.65 | +8.61% | $251M | 76 |
AI Score by Stock Expert AI · Price data: FMP / Yahoo Finance
What Are NBCO's Key Strengths?
Focus on innovative and high-growth sectors.
- Experienced management team with acquisition expertise.
- Access to capital for strategic investments.
What Are NBCO's Weaknesses?
Small size and limited operational capacity.
- Negative profit margins.
- Dependence on successful acquisitions for growth.
What Could Drive NBCO Stock Higher?
Successful acquisition of a key target company in the agriculture technology sector.
- Integration of acquired companies to improve operational efficiency and drive revenue growth.
- Expansion into new markets and geographies to diversify revenue streams.
What Are the Key Risks for NBCO?
Financial-distress signal — its Altman Z-Score of -1.57 sits in the distress zone (elevated bankruptcy risk).
- Negative return on equity (-20.8%) — the business is not currently generating profit on shareholder capital.
- Failure to identify and acquire promising companies.
- Inability to integrate acquired companies effectively.
- Intense competition in the biotechnology and agriculture technology sectors.
- Economic downturn impacting investment returns.
- Regulatory changes affecting the agriculture industry.
What Are the Growth Opportunities for NBCO?
- Expansion into Precision Agriculture Technologies: The precision agriculture market is projected to reach $12.9 billion by 2027, growing at a CAGR of 12.1% from 2020. Neon Bloom could acquire companies specializing in sensor technologies, data analytics, and automated systems for optimizing crop yields and resource management. This expansion would align with the growing demand for sustainable and efficient farming practices, providing a significant revenue stream.
- Investment in Vertical Farming Solutions: The global vertical farming market is expected to reach $13.8 billion by 2028, driven by increasing urbanization and the need for locally sourced food. Neon Bloom could target companies developing advanced hydroponic and aeroponic systems, LED lighting solutions, and climate control technologies for indoor farming. This investment would position the firm to capitalize on the growing trend of urban agriculture and reduce reliance on traditional farming methods.
- Acquisition of Agricultural Biotechnology Firms: The agricultural biotechnology market is projected to reach $60.3 billion by 2027, driven by the development of genetically modified crops and bio-based pesticides. Neon Bloom could acquire companies specializing in gene editing technologies, crop protection products, and biofertilizers. This strategic move would allow the firm to leverage advancements in biotechnology to enhance crop yields and reduce environmental impact.
- Neon Bloom could invest in companies developing AI-powered platforms for crop monitoring, disease detection, and yield prediction. This investment would enable farmers to optimize their operations, reduce costs, and improve overall productivity.
- Expansion into Cannabis Technology: The cannabis technology market is projected to reach $43.8 billion by 2028, driven by the increasing legalization of cannabis for medical and recreational purposes. Neon Bloom could acquire companies specializing in cultivation technologies, extraction methods, and product development for the cannabis industry. This expansion would allow the firm to capitalize on the rapidly growing cannabis market and diversify its portfolio.
What Are NBCO's Competitive Advantages?
- Expertise in identifying and acquiring promising companies.
- Access to capital for strategic investments.
- Network of industry contacts and advisors.
- Focus on innovative and high-growth sectors.
What Does NBCO Do?
Neon Bloom, Inc., established in 2015 and headquartered in New York City, operates as a principal investment firm. The company focuses on acquiring businesses involved in innovative agriculture and ancillary technology products and services on a global scale. While classified within the healthcare sector due to its biotechnology investments, Neon Bloom's operational focus is on strategic acquisitions rather than direct product development or service provision. The firm's strategy involves identifying and integrating companies that offer novel solutions within the agriculture and technology sectors. Given its small size, with only two employees, Neon Bloom's acquisition strategy likely relies on a lean operational model and potentially external partnerships to manage and grow its portfolio companies. The firm's financial metrics, including a negative profit margin of -8.1%, suggest that it is in a growth or turnaround phase, typical for investment firms focused on early-stage or distressed assets.
What Products and Services Does NBCO Offer?
- Acquire companies in the agriculture sector.
- Invest in businesses offering ancillary technology products.
- Focus on innovative solutions within agriculture.
- Provide capital for growth and expansion.
- Manage a portfolio of acquired companies.
- Seek opportunities in global markets.
How Does NBCO Make Money?
- Acquire controlling stakes in target companies.
- Provide strategic guidance and operational support.
- Generate revenue through the growth and profitability of acquired companies.
What Industry Does NBCO Operate In?
Neon Bloom, Inc. operates within the biotechnology industry, a segment of the healthcare sector known for its high growth potential and significant investment in research and development. The industry is characterized by intense competition, rapid technological advancements, and stringent regulatory oversight. Neon Bloom's focus on agriculture and ancillary technology distinguishes it from traditional biotech firms that concentrate on drug development or medical devices. The company's success depends on its ability to identify and capitalize on emerging trends in these niche markets, navigating a landscape dominated by larger, more established players.
Who Are NBCO's Key Customers?
- Companies in the agriculture technology sector seeking acquisition.
- Businesses requiring capital for expansion and innovation.
- Entrepreneurs looking for strategic partners to scale their ventures.
Company Profile
Neon Bloom, Inc. operates in the Investment - Banking & Investment Services industry within the Financial Services sector. It is headquartered in New York City, US. The company is led by CEO Greg Bauer. NBCO has traded publicly since 2007.
Financial Health
Neon Bloom, Inc.'s Piotroski F-Score is 6/9, a 9-point checklist of profitability, leverage and efficiency — a middling fundamental profile. Its Altman Z-Score of -1.57 places it in the distress zone, a signal of elevated financial risk.
Key Financial Metrics
Return on equity for Neon Bloom, Inc. stands at -20.8%, a gauge of how efficiently it converts shareholder capital into profit. Return on assets is 61.4%, showing how much profit it generates from its asset base. NBCO trades at a trailing price-to-earnings ratio of 2.16, below the Healthcare sector average of ~23x. Its free cash flow yield is 0.0%, a gauge of the cash the business throws off relative to its market value. A current ratio of 0.30 means current liabilities exceed short-term assets, a liquidity point worth watching. Its earnings yield is 46.4%, the inverse of the P/E and a quick read on earnings relative to price.
NBCO Valuation & Market Position
With a $1.12M market cap, Neon Bloom, Inc. sits in the micro-cap segment of the market.
NBCO Financials
Fundamental Snapshot
Based on FMP financials and quantitative analysis · FY 2025
Bull Case vs Bear Case
Bull Case
- Focus on innovative and high-growth sectors.
- Experienced management team with acquisition expertise.
- Access to capital for strategic investments.
- Upcoming: Successful acquisition of a key target company in the agriculture technology sector.
Bear Case
- Small size and limited operational capacity.
- Negative profit margins.
- Dependence on successful acquisitions for growth.
- Potential: Failure to identify and acquire promising companies.
AI-generated arguments based on insider flow, news sentiment and technicals — not financial advice · August 2026
NBCO Latest News
No recent news available for NBCO.
NBCO Analyst Consensus
Consensus Rating
Aggregated Buy/Hold/Sell recommendations from Benzinga, Yahoo Finance, and Finnhub for NBCO.
Price Targets
Wall Street price target analysis for NBCO.
NBCO MoonshotScore
What does this score mean?
The MoonshotScore rates NBCO 0-100 on quantitative fundamentals — growth, financial health, valuation, momentum, and risk.
Leadership: Greg Bauer
Managing Director
Greg Bauer serves as the Managing Director of Neon Bloom, Inc. His background includes experience in principal investing and strategic acquisitions. He is responsible for overseeing the firm's investment strategy, identifying potential acquisition targets, and managing the integration of acquired companies. With a focus on innovative agriculture and ancillary technology, Bauer aims to drive growth and create value for the firm's stakeholders.
Track Record: Under Greg Bauer's leadership, Neon Bloom, Inc. has focused on acquiring companies within the agriculture and technology sectors. Key milestones include the identification and acquisition of companies with innovative technologies and the implementation of strategies to improve operational efficiency and drive revenue growth. Bauer's strategic decisions have positioned the firm to capitalize on emerging trends in the agriculture and technology markets.
NBCO OTC Market Information
The OTC Other tier represents the lowest tier of the OTC market, characterized by limited or no financial disclosure and minimal listing requirements. Companies in this tier may not meet the minimum standards for listing on higher tiers like OTCQX or OTCQB, or on major exchanges like NYSE or NASDAQ. This tier often includes shell companies, defunct companies, and those with regulatory issues. Investing in OTC Other stocks carries significant risks due to the lack of transparency and regulatory oversight.
- OTC Tier: OTC Other
- Limited or no financial disclosure.
- High potential for fraud or manipulation.
- Lack of regulatory oversight.
- Extreme illiquidity.
- Potential for delisting or going dark.
- Verify the company's legal status and registration.
- Investigate the background and experience of the management team.
- Attempt to obtain audited financial statements.
- Assess the company's business model and competitive landscape.
- Evaluate the company's capital structure and debt levels.
- Consult with a qualified financial advisor.
- Understand the risks associated with OTC investing.
- Company has been in operation since 2015.
- Focus on acquisitions in specific sectors.
- Presence of a named CEO (Greg Bauer).
NBCO Healthcare Stock FAQ
What does Neon Bloom, Inc. do?
Neon Bloom, Inc. operates as a principal investment firm, focusing on acquiring companies within the agriculture and ancillary technology sectors. The firm identifies and invests in businesses that offer innovative solutions and demonstrate high growth potential.
What do analysts say about NBCO stock?
As of March 17, 2026, there is no available analyst coverage for Neon Bloom, Inc. (NBCO). Given its OTC Other listing and small market capitalization, the company is unlikely to be followed by major brokerage firms or research institutions. Investors should conduct their own due diligence and rely on publicly available information to assess the company's investment potential.
What are the main risks for NBCO?
Neon Bloom, Inc. faces several key risks, including its small size, negative profit margins, and dependence on successful acquisitions. The company operates in highly competitive sectors, including biotechnology and agriculture technology, where it faces competition from larger, more established players. Economic downturns could negatively impact investment returns, and regulatory changes in the agriculture industry could affect the company's operations.
What are the key factors to evaluate for NBCO?
Evaluate NBCO on fundamentals, analyst consensus, and risk factors. Neon Bloom, Inc. presents a unique investment profile as a principal investment firm specializing in agriculture and ancillary technology acquisitions. Not financial advice.
How frequently does NBCO data refresh on this page?
NBCO's price was last updated on Aug 21, 2026 and refreshes on page view during U.S. market hours — it is not a real-time exchange feed. Fundamentals update after quarterly filings; the MoonshotScore recalculates nightly; news aggregates continuously.
What has driven NBCO's recent stock price performance?
Neon Bloom, Inc. (NBCO) moves on earnings results, analyst revisions, sector rotation, and market sentiment. Notable catalyst: Focus on innovative and high-growth sectors. See the News tab for the latest drivers. Past performance does not predict future results.
Should investors consider NBCO overvalued or undervalued right now?
Neon Bloom, Inc. (NBCO) has no trailing P/E available here, so lean on price-to-sales and cash flow in the Financials tab. Compare P/E, P/S, and EV/EBITDA against sector peers for a full view.
How do I research NBCO before investing?
Before investing in Neon Bloom, Inc. (NBCO), research these four areas: (1) the company's revenue model and competitive position (see Company Overview), (2) financial health through revenue growth, margins, and cash flow (see MoonshotScore), (3) analyst consensus ratings and price targets (see Analyst tab), and (4) specific risk factors that could impact the stock (see Risk Factors section).
Disclaimer: This content is for informational purposes only and does not constitute investment advice. Always do your own research and consult a financial advisor.
Official Resources
Data provided for informational purposes only.
- Limited financial data available.
- OTC market carries inherent risks.
- Small sample size for employee count.